These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37523824)

  • 1. Preparation of a modified silk-based gel/microsphere composite as a potential hepatic arterial embolization agent.
    Chen C; Huang X; Wang F; Yin S; Zhu Y; Han L; Chen G; Chen Z
    Biomater Adv; 2023 Oct; 153():213559. PubMed ID: 37523824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and assessment of sodium alginate-modified silk fibroin microspheres as potential hepatic arterial embolization agent.
    Chen G; Wei R; Huang X; Wang F; Chen Z
    Int J Biol Macromol; 2020 Jul; 155():1450-1459. PubMed ID: 31734365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis.
    Xie F; Zang J; Guo X; Xu F; Shen R; Yan L; Yang J; He J
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):455-62. PubMed ID: 22179199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT/MR detectable magnetic microspheres for self-regulating temperature hyperthermia and transcatheter arterial chemoembolization.
    Wei C; Wu C; Jin X; Yin P; Yu X; Wang C; Zhang W
    Acta Biomater; 2022 Nov; 153():453-464. PubMed ID: 36167241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
    Li J; Wang N; Shi C; Liu Q; Song J; Ye X
    J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
    Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
    World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Zheng Z; Ma M; Han X; Li X; Huang J; Zhao Y; Liu H; Kang J; Kong X; Sun G; Sun G; Kong J; Tang W; Shao G; Xiong F; Song J
    Acta Biomater; 2023 Feb; 157():337-351. PubMed ID: 36509402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients.
    Lee SH; Lin CY; Hsu YC; Liu YS; Chuang MT; Ou MC
    Cancer Res Treat; 2020 Jan; 52(1):24-30. PubMed ID: 31048665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and characterization of hydroxyapatite/sodium alginate/chitosan composite microspheres for drug delivery and bone tissue engineering.
    Bi YG; Lin ZT; Deng ST
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():576-583. PubMed ID: 30948094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma.
    Nouri YM; Kim JH; Yoon HK; Ko HK; Shin JH; Gwon DI
    Korean J Radiol; 2019 Jan; 20(1):34-49. PubMed ID: 30627020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
    Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
    Carr BI; Kondragunta V; Buch SC; Branch RA
    Cancer; 2010 Mar; 116(5):1305-14. PubMed ID: 20066715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization.
    He JJ; Yin XX; Wang T; Chen MY; Li XL; Yang XJ; Shao HY
    J Cancer Res Ther; 2021 Jul; 17(3):777-783. PubMed ID: 34269313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
    Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
    Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step preparation of photoclick method for embolic microsphere synthesis and assessment for transcatheter arterial embolization.
    Zhao X; Huang W; Li X; Lin R; Li Q; Wu J; Yu Z; Zhou Y; Huang H; Yu M; Huang Y; Ye G
    Eur J Pharm Biopharm; 2021 Sep; 166():94-102. PubMed ID: 34118437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma.
    Furuse J; Ishii H; Satake M; Onaya H; Nose H; Mikami S; Sakai H; Mera K; Maru Y; Yoshino M
    Am J Clin Oncol; 2003 Apr; 26(2):159-64. PubMed ID: 12714888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization of liver cancer with drug-loading microsphere 50-100μm.
    Sun JH; Zhou GH; Zhang YL; Nie CH; Zhou TY; Ai J; Zhu TY; Wang WL; Zheng SS
    Oncotarget; 2017 Jan; 8(3):5392-5399. PubMed ID: 28036272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
    Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alginate-chitosan sustained release microcapsules for transhepatic arterial embolization in VX2 rabbit liver cancer model.
    Zhang GY; Zhou XF; Zhou XY; Wen QY; You BG; Liu Y; Zhang XN; Jin Y
    J Biomed Mater Res A; 2013 Nov; 101(11):3192-200. PubMed ID: 23554214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.